Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation PITX2_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-26039 | PITX2 | down-regulates | POU2F3 | represses | R-1707 | 16 | 1 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-26040 | PITX2 | down-regulates | POU4F1 | represses | R-2763 | 11 | 1 | Drugs (1) |
CMF-26041 | PITX2 | up-regulates | NR3C2 | activates | R-2018 | 2 | 1 | Drugs (3) |
CMF-26042 | PITX2 | down-regulates | GATA6 | represses | R-1253 | 18 | 1 | Drugs (9) Regulator Drugs (0)Regulon Drugs (9)AMG-780, MEDI-3617, ENIBARCIMAB, TREBANANIB, VANUCIZUMAB, PROBUCOL, FARICIMAB, CVX-060, NESVACUMAB |
CMF-26043 | PITX2 | down-regulates | GFI1 | represses | R-1217 | 13 | 1 | Drugs (11) Regulator Drugs (0)Regulon Drugs (11)BEVACIZUMAB, CONBERCEPT, PEGAPTANIB SODIUM, PEGAPTANIB OCTASODIUM, MUPARFOSTAT, VANUCIZUMAB, RANIBIZUMAB, FARICIMAB, ABICIPAR PEGOL, AFLIBERCEPT, BROLUCIZUMAB |
CMF-26044 | PITX2 | down-regulates | TRAF4 | activates | R-2273 | 14 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-42100 | PITX2 | down-regulates | hsa-mir-186 | represses | R-1459 | 10 | 1 | Drugs (1) |